Natixis

SEC CIK: 0001274981
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

PTGX holding history

Protagonist Therapeutics, Inc in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

PTGX overview All 13F holders of PTGX Full Q2 2026 holdings

Shares (Q2 2026): 7,776
Value: $953.2K
% of portfolio: <0.1%
Quarters held: 2; Since Q2 2025

Holdings of PTGX by Natixis, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	7,776	$953.2K	<0.1%	+7,776	New	Holders
Q3 2025	0	$0	0.0%	−42,040−100.0%	Sold out	Holders
Q2 2025	42,040	$2.32M	<0.1%	+42,040	New	Holders